Prothena Corp Public (PRTA) Deferred Taxes (2013 - 2025)
Prothena Corp Public (PRTA) posted quarterly Deferred Taxes of $44.9 million for Q2 2025, up 1699.39% year-over-year from $2.5 million in Q2 2024, and up 2786.06% quarter-over-quarter from -$1.7 million in Q1 2025.
Prothena Corp Public (PRTA) Deferred Taxes (2013 - 2025) Analysis & Trends
Prothena Corp Public's Deferred Taxes history runs 13 years deep, the most recent figure standing at $44.9 million for Q2 2025.
- In Q2 2025, Deferred Taxes rose 1699.39% year-over-year to $44.9 million; the TTM figure through Mar 2026 stood at $44.9 million (up 645.3% YoY), while the FY2025 annual figure was $43.2 million, up 562.65% from the prior year.
- Deferred Taxes for Q2 2025 stood at $44.9 million, up from -$1.7 million in the prior quarter.
- The five-year high for Deferred Taxes was $44.9 million in Q2 2025, with the low at -$4.5 million in Q2 2023.
- The 5-year median for Deferred Taxes is -$2.4 million (2022), against an average of $646888.9.
- The sharpest annual moves came in 2022 and 2025: Deferred Taxes sank 4088.89% in 2022, then soared 1699.39% in 2025.
- Prothena Corp Public's Deferred Taxes stood at -$568000.0 in 2021, then plunged by 468.66% to -$3.2 million in 2022, then fell by 23.13% to -$4.0 million in 2023, then soared by 43.75% to -$2.2 million in 2024, then soared by 2107.64% to $44.9 million in 2025.
- Business Quant data shows PRTA's Deferred Taxes at $44.9 million in Q2 2025, -$1.7 million in Q1 2025, and -$2.2 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -137,876.64 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.66 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Prothena Corp Public | 458.45 Mn | 170.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 44.91 Mn |
| Mar 31, 2025 | -1.67 Mn |
| Dec 31, 2024 | -2.24 Mn |
| Sep 30, 2024 | -1.52 Mn |
| Jun 30, 2024 | -2.81 Mn |
| Mar 31, 2024 | -2.78 Mn |
| Dec 31, 2023 | -3.98 Mn |
| Sep 30, 2023 | -3.97 Mn |
| Jun 30, 2023 | -4.51 Mn |
| Mar 31, 2023 | -3.23 Mn |
| Dec 31, 2022 | -3.23 Mn |
| Sep 30, 2022 | -3.02 Mn |
| Jun 30, 2022 | -2.37 Mn |
| Mar 31, 2022 | -2.52 Mn |
| Dec 31, 2021 | -568,000.00 |
| Sep 30, 2021 | -72,000.00 |
| Jun 30, 2021 | 591,000.00 |
| Mar 31, 2021 | 4.62 Mn |
| Dec 31, 2020 | -120,000.00 |
| Sep 30, 2020 | -507,000.00 |